These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35839019)

  • 1. Clinical and epidemiological features of healthcare workers after a coronavirus disease 2019 cluster infection in Japan and the effects of Kampo formulas-Hochuekkito and Kakkonto: A retrospective cohort study.
    Ogawa-Ochiai K; Ishikawa H; Nishimura H; Okajima M; Iinuma Y; Ito M
    Medicine (Baltimore); 2022 Jul; 101(28):e29748. PubMed ID: 35839019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological and Preventive Effects of Hochuekkito and Kakkonto Against Coronavirus Disease in Healthcare Workers: A Retrospective Observational Study.
    Ogawa-Ochiai K; Ishikawa H; Li H; Vu Quang L; Kimoto I; Takamura M; Hongawa T; Hane Y; Suzuki S; Okajima M; Mori K; Ito M; Takami A
    Front Pharmacol; 2021; 12():766402. PubMed ID: 34867392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A structured summary of a study protocol for a multi-center, randomized controlled trial (RCT) of COVID-19 prevention with Kampo medicines (Integrative Management in Japan for Epidemic Disease by prophylactic study: IMJEDI P1 study).
    Namiki T; Takayama S; Arita R; Ishii T; Kainuma M; Makino T; Mimura M; Yoshino T; Nogami T; Arai M; Sato J; Tanaka K; Nakae H; Igari H; Ozawa Y; Shiko Y; Kawasaki Y; Nezu M; Ito T
    Trials; 2021 Jan; 22(1):23. PubMed ID: 33407828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to-moderate COVID-19 patients for symptomatic relief and prevention of severe stage: a structured summary of a study protocol for a randomized controlled trial.
    Takayama S; Namiki T; Ito T; Arita R; Nakae H; Kobayashi S; Yoshino T; Ishigami T; Tanaka K; Kainuma M; Nochioka K; Takagi A; Mimura M; Yamaguchi T; Ishii T
    Trials; 2020 Oct; 21(1):827. PubMed ID: 33008479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Ninjin'yoeito in treating severe coronavirus disease 2019 in patients in an intensive care unit.
    Aomatsu N; Shigemitsu K; Nakagawa H; Morooka T; Ishikawa J; Yamashita T; Tsuruoka A; Fuke A; Motoyama K; Kitagawa D; Ikeda K; Maeda K; Shirano M; Rinka H
    Neuropeptides; 2021 Dec; 90():102201. PubMed ID: 34753072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive infection control measures prevent hospital-acquired severe acute respiratory syndrome coronavirus 2 infection: A single-center prospective cohort study and seroprevalence survey.
    Hori H; Fukuchi T; Sanui M; Moriya T; Sugawara H
    PLoS One; 2021; 16(10):e0257513. PubMed ID: 34634076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conventional and Kampo Medicine Treatment for Mild-to-moderate COVID-19: A Multicenter, Retrospective, Observational Study by the Integrative Management in Japan for Epidemic Disease (IMJEDI Study-observation).
    Takayama S; Yoshino T; Koizumi S; Irie Y; Suzuki T; Fujii S; Katori R; Kainuma M; Kobayashi S; Nogami T; Yokota K; Yamazaki M; Minakawa S; Chiba S; Suda N; Nakada Y; Ishige T; Maehara H; Tanaka Y; Nagase M; Kashio A; Komatsu K; Nojiri M; Shimooki O; Nakamoto K; Arita R; Ono R; Saito N; Kikuchi A; Ohsawa M; Nakae H; Mitsuma T; Mimura M; Ishii T; Nochioka K; Chiu SW; Yamaguchi T; Namiki T; Hisanaga A; Mitani K; Ito T
    Intern Med; 2023 Jan; 62(2):187-199. PubMed ID: 36328579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of traditional Japanese Kampo medicines, kakkonto with shosaikotokakikyosekko, in treating patients with mild-to-moderate coronavirus disease 2019: Further analysis of a multicenter, randomized controlled trial.
    Takayama S; Namiki T; Arita R; Ono R; Kikuchi A; Ohsawa M; Saito N; Suzuki S; Nakae H; Kobayashi S; Yoshino T; Ishigami T; Tanaka K; Takagi A; Yamaguchi T; Ishii T; Hisanaga A; Mitani K; Ito T
    J Infect Chemother; 2023 Nov; 29(11):1054-1060. PubMed ID: 37507087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological and clinical characteristics of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among healthcare workers in Hubei Province, China.
    Wu M; Xie C; Wu R; Shu Y; Wang L; Li M; Wang Y
    Infect Control Hosp Epidemiol; 2021 Aug; 42(8):924-930. PubMed ID: 33203485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reconstruction of transmission chains of SARS-CoV-2 amidst multiple outbreaks in a geriatric acute-care hospital: a combined retrospective epidemiological and genomic study.
    Abbas M; Cori A; Cordey S; Laubscher F; Robalo Nunes T; Myall A; Salamun J; Huber P; Zekry D; Prendki V; Iten A; Vieux L; Sauvan V; Graf CE; Harbarth S
    Elife; 2022 Jul; 11():. PubMed ID: 35850933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serology suggests adequate safety measures to protect healthcare workers from COVID-19 in Shiga Prefecture, Japan.
    Chano T; Morita SY; Suzuki T; Yamashita T; Fujimura H; Yuri T; Menju M; Tanaka M; Kakuno F
    PLoS One; 2022; 17(6):e0270334. PubMed ID: 35749426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of Kampo Medicines for Treatment of General Fatigue Due to Long COVID.
    Tokumasu K; Ueda K; Honda H; Sunada N; Sakurada Y; Matsuda Y; Nakano Y; Hasegawa T; Otsuka Y; Obika M; Hagiya H; Kataoka H; Otsuka F
    Medicina (Kaunas); 2022 May; 58(6):. PubMed ID: 35743993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical interventions to interrupt or reduce the spread of respiratory viruses.
    Jefferson T; Del Mar CB; Dooley L; Ferroni E; Al-Ansary LA; Bawazeer GA; van Driel ML; Jones MA; Thorning S; Beller EM; Clark J; Hoffmann TC; Glasziou PP; Conly JM
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD006207. PubMed ID: 33215698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The experience of the health care workers of a severely hit SARS-CoV-2 referral Hospital in Italy: incidence, clinical course and modifiable risk factors for COVID-19 infection.
    Colaneri M; Novelli V; Cutti S; Muzzi A; Resani G; Monti MC; Rona C; Grugnetti AM; Rettani M; Rovida F; Zuccaro V; Triarico A; Marena C
    J Public Health (Oxf); 2021 Apr; 43(1):26-34. PubMed ID: 33140084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of government pandemic policies on the vulnerability of healthcare workers to SARS-CoV-2 infection and mortality in Jakarta Province, Indonesia.
    Agustina R; Rianda D; Lamuri A; Ekawidyani KR; Siregar DAS; Sari DS; Wulan PM; Devana ND; Syam AF; Rahyussalim AJ; Handayani DO; Widyastuti W; Shankar AH; Salama N
    Ann Med; 2023; 55(2):2293306. PubMed ID: 38206905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The appropriateness of the decision to quarantine healthcare workers exposed to a severe acute respiratory coronavirus virus 2 (SARS-CoV-2)-positive coworker based on national guidelines.
    Mark E; Saidel-Odes L; Borer A; Nativ R; Sterer B; Yarmitsky S; Dreiher J
    Infect Control Hosp Epidemiol; 2023 Jun; 44(6):920-925. PubMed ID: 35982579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of Coronavirus Disease 2019 (COVID-19) among healthcare workers during the first and second wave in the Democratic Republic of the Congo: a descriptive study.
    Milambo JPM; Ndirangu J; Mangala S; Simba H; Kabego L
    BMC Infect Dis; 2023 Aug; 23(1):519. PubMed ID: 37553564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transmission of SARS-CoV-2 among healthcare workers and patients in a teaching hospital in the Netherlands confirmed by whole-genome sequencing.
    Paltansing S; Sikkema RS; de Man SJ; Koopmans MPG; Oude Munnink BB; de Man P
    J Hosp Infect; 2021 Apr; 110():178-183. PubMed ID: 33571558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-infection of malaria and early clearance of SARS-CoV-2 in healthcare workers.
    Mahajan NN; Gajbhiye RK; Bahirat S; Lokhande PD; Mathe A; Rathi S; Warty N; Mahajan KN; Srivastava V; Kuppusamy P; Mohite SC
    J Med Virol; 2021 Apr; 93(4):2431-2438. PubMed ID: 33368412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of Vaccine Breakthrough SARS-CoV-2 Infection and Associated Factors in Healthcare Workers of Trieste Teaching Hospitals (North-Eastern Italy).
    Basso P; Negro C; Cegolon L; Larese Filon F
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215930
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.